Business profile not generated.
Run python -m application.cli.business_profile run --market US --one RVPH, then regenerate the site.
Issue 000 | U.S. Pilot | US
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Passing
Verified
10-Q | 2026-05-13
Filing currency: USD
Margin of Safety
51.5%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 23,559,636USD
- Total Liabilities
- 6,119,155USD
- NCAV
- 17,440,481USD
- Cash
- 22,190,231USD
- NCAV per share
- 1.36USD/share
- Evidence
- 8 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
2020-12-31
10-K
USD
|
2020-02-29
10-K
USD
|
2019-02-28
10-K
USD
|
|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -20,200,031 | -30,798,889 | -39,503,636 | -24,306,608 | -10,104,513 | -2,434,651 | -724,740 | -152,789 |
| Net Income | -19,864,902 | -29,918,802 | -39,260,837 | -24,339,292 | -8,521,876 | -3,783,388 | 617,903 | 574,131 |
| Cash From Operations | -24,594,643 | -33,543,916 | -28,324,353 | -18,960,581 | -10,668,462 | -3,725,692 | -426,591 | -220,869 |
| Capex | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cash And Equivalents | 14,438,792 | 13,476,331 | 23,367,456 | 18,519,856 | 29,687,944 | 8,760,462 | 69,276 | 313,049 |
| Accounts Receivable | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 15,103,477 | 14,683,367 | 23,700,388 | n/a | n/a | n/a | 138,860 | 404,179 |
| Total Assets | 15,923,198 | 15,503,088 | 23,700,388 | 18,923,675 | 31,404,001 | 8,762,278 | 61,021,809 | 65,646,099 |
| Total Current Liabilities | 7,275,553 | 14,601,506 | 17,175,017 | 6,039,840 | 2,344,811 | 1,332,743 | 299,653 | 23,050 |
| Total Liabilities | 7,275,553 | 14,690,516 | 17,981,672 | 6,607,279 | 2,717,541 | 1,332,743 | 3,263,403 | 2,236,800 |
| Shareholders Equity | 8,647,645 | 812,572 | 5,718,716 | 12,316,396 | 28,686,460 | 7,429,535 | 5,000,007 | 5,000,008 |
| Shares Outstanding | 5,872,865 | 46,579,199 | 27,918,560 | 20,447,371 | 14,433,286 | 9,231,737 | 2,704,587 | 2,602,465 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Basic | 3,627,890 | 33,147,424 | 23,798,203 | 19,516,479 | 14,790,843 | n/a | n/a | n/a |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -3,271,952 | -3,559,041 | -4,029,841 | -6,072,982 | -6,538,167 | -6,284,606 | -8,462,534 | -8,129,643 | -7,922,106 | -9,988,485 | -10,709,047 | -12,070,551 | -6,735,553 | -7,774,010 | -3,562,953 | -5,519,488 | -7,450,157 | -3,964,643 | -2,476,840 | -1,790,902 |
| Net Income | -3,195,987 | -3,367,679 | -4,010,773 | -6,053,610 | -6,432,840 | -6,259,477 | -8,365,798 | -7,859,919 | -7,433,608 | -9,724,403 | -10,491,029 | -12,442,862 | -6,602,543 | -8,118,272 | -3,515,308 | -5,340,704 | -7,365,008 | -3,684,953 | -2,279,216 | -1,608,407 |
| Cash From Operations | -3,801,296 | -5,798,211 | -5,589,486 | -5,012,748 | -8,194,198 | -9,100,497 | -4,241,422 | -8,476,188 | -11,725,809 | -8,876,445 | -6,179,284 | -5,317,227 | -7,951,397 | -4,690,634 | -4,001,995 | -4,001,175 | -6,266,777 | -3,902,153 | -2,309,325 | -1,340,741 |
| Capex | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cash And Equivalents | 22,190,231 | 14,438,792 | 13,183,259 | 10,363,714 | 5,289,404 | 13,476,331 | 5,558,817 | 6,178,180 | 11,973,647 | 23,367,456 | 4,972,298 | 11,151,582 | 11,255,552 | 18,519,856 | 23,191,927 | 19,420,062 | 23,421,237 | 29,687,944 | 33,491,616 | 35,800,941 |
| Total Current Assets | 23,559,636 | 15,103,477 | 13,512,928 | 10,815,125 | 6,257,325 | 14,683,367 | 6,810,151 | 7,232,953 | n/a | 23,700,388 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | 6,119,155 | 7,275,553 | 9,782,914 | 12,093,993 | 11,537,070 | 14,690,516 | 17,611,760 | 14,094,196 | 14,842,447 | 17,981,672 | 13,906,473 | 10,220,835 | 7,116,550 | 6,607,279 | 3,681,431 | 4,583,081 | 3,907,194 | 2,717,541 | 1,624,586 | 2,013,902 |
| Shares Outstanding | 12,810,377 | 5,872,865 | 96,337,119 | 68,003,613 | 46,739,949 | 46,579,199 | 33,441,199 | 29,817,294 | 27,918,560 | 27,918,560 | 20,650,266 | 22,650,266 | 20,452,121 | 20,447,371 | 20,442,871 | 14,433,286 | 15,133,286 | 14,433,286 | 13,388,986 | 13,388,986 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Basic | 7,022,945 | 3,627,890 | 72,685,740 | 49,847,872 | 48,644,339 | 33,147,424 | 33,804,693 | 30,555,012 | 29,887,325 | 23,798,203 | 24,033,665 | 22,434,781 | 21,833,598 | 19,516,479 | 19,269,989 | 18,466,586 | 18,466,586 | 14,790,843 | 18,455,586 | 12,874,961 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 23,559,636USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001742927/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001742927\companyfacts.json |
| Total Liabilities | 6,119,155USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001742927/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001742927\companyfacts.json |
| Cash | 22,190,231USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001742927/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001742927\companyfacts.json |
| Shares Outstanding | 12,810,377 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001742927/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001742927\companyfacts.json |
| NCAV | 17,440,481USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 1.36USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 51.5% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001742927
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001742927\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001742927\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 23
- Imported At
- 2026-07-04T23:04:37+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001437749-26-016762
- CIK
- 0001742927
- Mary Filing Date
- 2026-05-13
- Filing Currency
- USD
- Internal Discount
- 51.5%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-13; mary_accession=0001437749-26-016762; mary_cik=0001742927; gnni_supporting_filing_date=2026-05-13; internal_discount=0.515217; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.